Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
4.110
-0.010 (-0.24%)
At close: Jul 31, 2026, 4:00 PM EDT
4.100
-0.010 (-0.24%)
After-hours: Jul 31, 2026, 4:10 PM EDT

Apyx Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Apyx Medical stock has a consensus rating of "Strong Buy" and an average price target of $6.60. The average 1-year stock price forecast is 60.58% higher than the current stock price, while the lowest is $6.00 (+45.99%) and the highest is $8.00 (+94.65%).

Price Target: $6.60 (+60.58%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$6.00$6.60$6.00$8.00
Change+45.99%+60.58%+45.99%+94.65%

Analyst Ratings

The average analyst rating for Apyx Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJan '26Feb '26Mar '26Apr '26May '26Jul '26
Strong Buy334434
Buy111111
Hold110000
Sell000000
Strong Sell000000
Total555545

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Initiates
$7
BuyInitiates$7+70.32%Jul 13, 2026
Craig-Hallum
Craig-Hallum
Buy
Reiterates
$6
BuyReiterates$6+45.99%May 8, 2026
Roth MKM
Roth MKM
Buy
Reiterates
$6
BuyReiterates$6+45.99%Apr 14, 2026
BTIG
BTIG
Buy
Upgrades
$6
BuyUpgrades$6+45.99%Mar 11, 2026

Financial Forecast

Revenue This Year
59.55M
from 52.84M
Increased by 12.70%
Revenue Next Year
66.12M
from 59.55M
Increased by 11.02%
EPS This Year
-0.27
from -0.27
EPS Next Year
-0.25
from -0.27
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
48.52M44.51M52.35M48.10M52.84M59.55M
Revenue Growth
75.08%-8.26%17.61%-8.11%9.86%12.70%
Gross Profit
33.60M29.13M33.76M29.36M33.04M37.10M
Gross Margin
69.26%65.45%64.49%61.04%62.53%62.30%
Operating Income
-14.45M-23.31M-19.95M-18.85M-6.45M-6.12M
Net Income
-15.17M-23.18M-18.71M-23.46M-11.21M-11.02M
EPS
-----0.27-0.27
Free Cash Flow
-5.33M-5.54M-1.90M-11.58M-7.11M-10.20M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High59.9M
Avg59.6M
Low59.3M

Revenue Growth

Revenue Growth202620272028
High
13.4%
Avg
12.7%
Low
12.3%

EPS Forecast

EPS202620272028
High-0.21
Avg-0.27
Low-0.31

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-